Switch to
More onapp

How to use scorecard? Learn more

Adline Chem Lab Ltd

ADLINE
Pharmaceuticals
SmallcapWith a market cap of ₹15 cr, stock is ranked 4,216
Moderate RiskStock is 2.65x as volatile as Nifty
26.010.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Low

Profitability and efficiency haven't been upto the mark

Entry point

Bad

The stock is in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Pharmaceuticals
SmallcapWith a market cap of ₹15 cr, stock is ranked 4,216
Moderate RiskStock is 2.65x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-95.10
PB RatioPB Ratio
-8.90
Dividend YieldDiv. Yield
Sector PESector PE
0
Sector PBSector PB
0
Sector Div YldSctr Div Yld

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Kamron Laboratories is engaged in the manufacturing and trading of pharmaceutical products.

Financial TrendFinancial statements 

20212022202320246.332.071.000.03-1.280.73-4.23-0.15
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnOct 26, 2024

Adline Chem Lab Ltd - 524604 - Board Meeting Intimation for Intimation Regarding Postponement Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | Download

Adline Chem Lab Ltd - 524604 - Board Meeting Intimation for Intimation Regarding Postponement Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | Download

Board Meeting 
Announced OnOct 22, 2024

Adline Chem Lab Ltd - 524604 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | Download

Adline Chem Lab Ltd - 524604 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | Download

Company Update 
Announced OnOct 7, 2024

Adline Chem Lab Ltd - 524604 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Download

Adline Chem Lab Ltd - 524604 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Download

See all events